| Literature DB >> 32252182 |
Jeong Man Cho1, Kyong Tae Moon1, Tag Keun Yoo1.
Abstract
Increasingly many studies have presented robotic simple prostatectomy (RSP) as a surgical treatment option for large benign prostatic hyperplasia (BPH) weighing 80-100 g or more. In this review, some frequently used RSP techniques are described, along with an analysis of the literature on the efficacy and complications of RSP and differences in treatment results compared with other surgical methods. RSP has the advantage of a short learning curve for surgeons with experience in robotic surgery. Severe complications are rare in patients who undergo RSP, and RSP facilitates the simultaneous treatment of important comorbid diseases such as bladder stones and bladder diverticula. In conclusion, RSP can be recommended as a safe and effective minimally invasive treatment for large BPH.Entities:
Keywords: Lower urinary tract symptoms; Prostatectomy; Prostatic hyperplasia
Year: 2020 PMID: 32252182 PMCID: PMC7136446 DOI: 10.5213/inj.2040018.009
Source DB: PubMed Journal: Int Neurourol J ISSN: 2093-4777 Impact factor: 2.835
Fig. 1.Configuration of ports for robotic simple prostatectomy.
Fig. 2.Example of a robotic simple prostatectomy procedure. (A) After cystotomy, protrusion of a prostatic adenoma into the bladder was found. (B) Retraction sutures on the adenoma facilitated enucleation. (C) Dissection was performed between the adenoma and prostatic parenchyma. (D) After the dissection was complete, the urethra could be cut under direct vision. (E) After cutting the urethra, the Foley catheter could be seen. (F) Shape of the prostatic fossa after removal of the adenoma. (G) Capsular plication and bladder neck reconstruction. (H) Closure of cystotomy.
Fig. 3.PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. RSP, robotic simple prostatectomy.
Characteristics and perioperative outcomes of the included studies
| Year of publication | 2012 | 2015 | 2016 | 2016 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Study | Matei et al. [ | Pokorny et al. [ | Martín Garzón et al. [ | Martín Garzón et al. [ | Pavan et al. [ | Zhang et al. [ | Johnson et al. [ | Nestler et al. [ |
| No. of patients | 35 | 67 | 79 | 76 | 130 | 32 | 12 | 35 |
| No. of surgeons | - | 2 | 1 | 1 | 3 or more | 2 | 2 | |
| Age (yr) | 65.5 | 69 | 69.5 | 64.5 | 67.4 | 71 | 70 | 70.9 |
| Mean operative time (min) | 186 | 97 | - | - | 150 | 274 | 157 | 182 |
| Estimate blood loss (mL) or Hemoglobin change | 121 mL | 200 mL | 390 mL | 535 mL | 250 mL | -2.5 g/dL | -5.4 % | -1.5 g/dL |
| Duration of Foley catheter indwelling (day) | 7.4 | 3 | 9.1 | 9.4 | 5 | 8 | 4 | 5 |
| Hospitalization period (day) | 3.17 | 4 | - | - | 5 | 8 | 4 | 5 |
| preoperative PSA (mg/dL) | 5.44 | 6.5 | 6.7 | 10 | 6.1 | 6.4 | ||
| Preoperative prostate volume (g) | 106.6 | 129 | 80.3 | 75.5 | 118.5 | 121.5 | 94.5 | |
| Resection volume (g) | 87.04 | 84 | - | - | 77 | 110 | 61.2 | 77 |
| Preoperative IPSS | 28 | 25 | 22.7 | 20.9 | 23 | - | - | 23 |
| Postoperative IPSS | 7 | 3 | 5.8 | 6.2 | 5 | - | - | - |
| Transfusion rate (%) | 0 | 1.5 | 6.3 | 6.3 | 9.4 | 3.3 | 9.4 | |
| Surgical route | Transvesical | - | Millin (retropubic) | Intrafascial | Trans and extraperitoneal | - | - | - |
| Major complication rate (%) | - | 4.5 | 3.9 | 1.2 | 2.3 | 3.1 | 7.5 | - |
| Participation center (single or multi) | Single | Single | Single | Single | Single | Single | Single | - |
| Comparable study | - | - | vs. LSP | vs. LSP | vs. LSP | vs. HoLEP | Learning curve | vs. OSP, ThuVEP |
| Cancer detection rate (%) | - | - | 5.06 | 26 | 0.8 | - | 11 | - |
IPSS, International Prostate symptom Score; LSP, laparoscopic simple prostatectomy; OSP, open simple prostatectomy; HoLEP, holmium laser enucleation of the prostate; ThuVEP, thulium vapoenucleation of the prostate.